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Introduction 41
The continued efficacy of β-lactam antibiotics is threatened by the dissemination of β-42 lactamases, hydrolytic enzymes that inactivate these important drugs by cleavage of the scissile 43 β-lactam amide bond (1). In the 70 years since β-lactams were first introduced to the clinic, 44 repeated mobilizations of β-lactamase genes from a variety of bacterial sources have led to their 45 rapid propagation in opportunistic Gram-negative pathogens such as the Enterobacteriaceae and 46 non-fermenting species including Pseudomonas aeruginosa and Acinetobacter baumannii (2). 47
Notably, some of the most successful β-lactamases, in particular the CTX-M extended-spectrum 48 β-lactamase (ESBL) associated with resistance to third-generation cephalosporins such as 49 cefotaxime, and which is now distributed worldwide (3), find their origins in environmental 50 organisms, illustrating how transfer of antibiotic resistance genes from environmental to 51 pathogenic species can have profound clinical consequences (4). In the case of CTX-M enzymes 52
it is now accepted that these originated in Kluyvera spp. (5, 6), a Gram-negative rod bacterium 53 that is found in both the human intestinal microbiome and the wider natural environment (7) . 54 β-Lactamases are divided, primarily on the basis of amino acid sequence, into four main classes 55 (8). Of these, three (classes A, C and D) are active site nucleophilic serine enzymes (SBLs) and 56 the remaining class, B, zinc metalloenzymes that are structurally and mechanistically unrelated 57 to the SBLs. The metallo-β-lactamases (MBLs) are themselves divided into a further three 58 groups (B1, B2 and B3) on the basis of sequence differences that are manifest as variations in the 59 number (1 or 2) of zinc ions required for full activity, and in structural differences that include 60 variations in co-ordination of the active site zinc ions (9, 10). MBLs are a growing clinical 61 concern as they effectively hydrolyze all β-lactam classes excepting the monobactams and escape the action of SBL inhibitors (11) that are at (clavulanate, tazobactam) or close to 63 (avibactam, relebactam) the clinic. B1 MBLs such as the NDM (12) and VIM (13) enzymes are 64 now encountered with increasing frequency on mobile genetic elements in organisms such as 65
Escherichia coli, Klebsiella pneumoniae, P. aeruginosa and A. baumannii. 66
While B3 family members such as AIM-1 (14) and SMB-1 (15) have been identified on mobile 67 genetic elements, the majority of these enzymes are chromosomal. However, in addition to their 68 presence in opportunist pathogens such as Stenotrophomonas maltophilia (16) and 69
Elizabethkingia meningosepticum (17), the B3 MBLs also have a very wide distribution in 70 environmental organisms and sequences. Compared to the B1 enzymes, the B3 MBLs are less 71 well studied, display a greater degree of structural and sequence diversity and are more closely 72 related to other branches of the wider metallo-hydrolase superfamily to which the MBLs belong 73 (18). Investigations of B3 MBLs from environmental sources will thus expand our understanding 74 of activity and structure within this group of enzymes and provide insights into the nature and 75 extent to which MBLs in the environment provide a reservoir of resistance determinants to the 76 most clinically important β-lactam antibiotics. Furthermore, identifying how the distribution of 77 such sequences changes in response to human activity (i.e. exposure to antimicrobials within the 78 environment) can also provide evidence of the effect of human activity upon the environmental 79 resistance reservoir (19) . 80
Technological advances have transformed our ability to sample and identify antibiotic resistance 81 genes in the natural environment. In particular, combining sequence-based (metagenomics) with 82 functional (construction and analysis of large libraries) methodologies can both establish the 83 prevalence and distribution of putative resistance genes and identify those that confer a 84 resistance phenotype, i.e that are able to alter antibiotic susceptibility in a model organism (e.g. 85 E. coli) (20) (21) (22) . This study provides a biochemical and structural characterization of a B3 MBL, 86
Rm3, that was identified by application of this functional metagenomics approach to study the 87 distribution of resistance to third-generation cephalosporins in environmental sources selected on 88 the basis of differing degrees of human impact. (Full details of the identification of Rm3 will be 89 presented elsewhere). The bla Rm3 gene (GenBank accession KF485393.2) was isolated from a 90 metagenomic library derived from soil from a reed bed used to bioremediate effluent from a 91 textile mill with high usage of quaternary ammonium compounds (QACs). Screening of this 92 library identified bla Rm3 as one of a number of novel β-lactamase genes able to decrease 93 susceptibility of recombinant E. coli to third generation cephalosporins. 94
The Rm3 amino acid sequence ( Figure 1) 
Materials and Methods 109

Identification of bla Rm3 110
Full details of the identification of Rm3 will be presented elsewhere. Briefly, core samples were 111 obtained from reed beds used for remediation of effluent from a textile mill in Yorkshire, U.K., 112 (27) and total DNA was purified as previously described (21). A metagenomic library was 113 generated by cloning purified DNA fragments into plasmid pCF430 (28) and transforming into 114 E. coli strain EC100 (Epicentre, Madison WI, U.S.A.) by electroporation. Recombinants were 115 passaged over 10-20 generations and clones resistant to third generation cephalosporins selected 116 by plating on ceftazidime (1 μg / ml). Putative resistance genes were identified by sequencing 117 positive clones, and their contribution to the resistance phenotype confirmed by inactivation 118 using transposon mutagenesis (EZ-Tn5 kit, Epicentre) allowing for selection by loss of 119 phenotype (21). 120 121
Minimal Inhibitory Concentration (MIC) Determination for Metagenomic Clones 122
Minimal inhibitory concentration (MIC) values for metagenomic clones were determined by agar 123 dilution on Iso-sensi Test Agar (Oxoid) with an inoculum of 10 5 colony forming units (cfu) per 124 spot (29). 125 126
Recombinant Rm3 Expression and Purification 127
The complete Rm3 open reading frame (including the putative periplasmic export sequence) was 128 amplified from metagenomic clone RM3 by PCR with primers RM3F 129 (AAGGCATATGATGTCCCTCACACCACCACGCGCG) and RM3R2(AATGGGATCCTTAC 130 TGCTGTTTTTCCTGGT) with proof-reading Pfu DNA polymerase. The product was ligated 131 into the T7 expression vector pET26b (30) using the Nde1 and BamH1 restriction sites and the 132 integrity of the resulting plasmid pLHZRM3 confirmed by DNA sequencing. E. coli The instrument was connected to a CTC-autosampler inlet system. A multi-step gradient over 166 10 min was run (solvent A 94.9% H 2 O/5% CH 3 CN/0.1% formic acid, solvent B 99.9% 167 CH 3 CN/0.1% formic acid; 0-1 min 5% B for equilibration, followed by a linear gradient to 168 100% B over 4 min, then 100% B for an additional 3 min, followed by a linear gradient over 2 169 min back to 5% B to re-equilibrate the column) to separate the protein samples at flow rates of 170 0.4 ml / min for the first 5 min and then 1.0 ml / min for the remaining time. The electrospray 171 ionization source used a capillary voltage of 3.2 kV and cone voltage of 25 V. Nitrogen was used 172 as the nebulizer and desolvation gas at a flow rate of 600 l/h. Protein typically eluted as a peak between 3 and 5 min under these conditions. Calculated masses were obtained using the ExPasy 174
ProtParam tool (http://web.expasy.org/protparam/ (33)). wavelengths used (34) were: -775 M -1 cm -1 at 235 nm (penicillin G); -820 M -1 cm -1 at 235 nm 183 (ampicillin); -7700 M -1 cm -1 at 260 nm (cefoxitin); -9000 M -1 cm -1 at 260 nm (ceftazidime); -184 7500 M -1 cm -1 -at 260 nm (cefotaxime); -6500 M -1 cm -1 at 300 nm (meropenem); -9000 M -1 cm -1 185 at 300 nm (imipenem); and -700 M -1 cm -1 at 320 nm (aztreonam). the predicted precursor polypeptide after residue 23. Thus these data confirm that the leader 248 peptide is removed from recombinant Rm3 by post-translational processing in E. coli, and 249 strongly indicate that, as is the case for other β-lactamases of Gram-negative bacteria, the protein 250 is exported to the bacterial periplasm. 251
Steady-state kinetic experiments indicate that Rm3 is able to hydrolyze a range of penicillin, 252 cephalosporin, and carbapenem antibiotics with varying degrees of efficiency (Table 2) Erwinia caratovora CAR-1 (50) and Caulobacter crescentus CAU-1 (51), are also notable for 268 comparably high K M values across the range of β-lactams. However, Rm3 is distinguished from many of these by an apparent lack of discrimination against oxyiminocephalosporins (e.g. 270 ceftazidime) or 7-α-methoxy cephalosporins (e.g. cefoxitin) that are poor substrates for the B3 271 enzymes CAR-1 and CAU-1, respectively. k cat /K M values for hydrolysis of these substrates by 272
Rm3 are in line with those for other β-lactams tested. and refinement statistics are given in Table 3 . The final structure contains 268 (chain A) and 269 279 (chain B) residues, with electron density not observed for the 10 (chain A) or 9 (chain B) N-280 terminal amino acids, or for the C-terminal glutamine residue of either polypeptide chain. We 281 note that the N-terminus of processed Rm3 is formed by a proline-rich sequence (QTPAPATPP) 282 that is likely to be unstructured in solution. 96.6 % of total residues are in the most favored 283 regions of the Ramachandran plot, with no residues classed as outliers. The overall structure 284 ( Figure 3) is that of the MBL superfamily, comprising an αβ / βα fold in which the N-and C-285 terminal halves of the protein form central seven-and five-stranded β-sheets, respectively, that 286 are flanked by α-helices. The interface of these two sheets provides the location for the active 287 site. The active site environment is defined by three loop regions that connect elements of 288 secondary structure: residues 150 -164 (loop 1) connecting helix α4 and strand β7; residues 192 289 -201 that connect strands β9 and β10 and residues 222 -239 (loop 2) connecting strand β11 and 290 helix α5. (The BBL numbering scheme (52) is used throughout this manuscript).
The presence of disulfide bonds also serves to define the overall architecture of the Rm3 292 structure. The processed Rm3 polypeptide contains a total of 6 Cys residues, of which two 293 (residues 256 and 290) form a disulfide bond between helices α5 and α7 that is common to all 294 B3 MBLs of known structure excepting BJP-1 (53). In chain A of the current structure a second 295 disulfide between Cys208 and Cys213 constrains the short loop between strands β10 and β11. also contribute to a further zinc site at the interface between the two Rm3 molecules present in 301 the crystallographic asymmetric unit, in which zinc co-ordination is completed by His158 of the 302 opposing chain, and by a crystallographic water molecule. However, as Rm3 eluted from the size 303 exclusion chromatography column at a volume consistent with a molecular weight of 304 approximately 30 000 Da (data not shown), indicating that the protein is likely to exist as a 305 monomer in solution, we consider both of these interface sites to be crystallization artefacts that 306 are unlikely to exert a physiological function. 307
Inspection of difference electron density maps from the early stages of refinement 308 unambiguously identified the presence of two metal ions in the Rm3 active site. These were 309 refined as zinc ions, based upon the presence of excess zinc in the crystallization experiment and 310 the absence of other metal ions in the crystal as adjudged by the lack of additional peaks in an X-311 ray fluorescence excitation spectrum collected at the synchrotron beamline (data not shown). 312
Both sites were refined to 100 % occupancy with B-factors similar to those of the adjacent 313 protein atoms (Table 3) . Consistent with assignment of Rm3 as a member of the B3 MBL subfamily, the two zinc ions respectively occupy the two binding sites that are defined by 315 conserved residues of the MBL superfamily; i.e. a tri-histidine (Zn1) site formed by His116, 316
His118 and His196 and an Asp -His -His (Zn2) site formed by Asp120, His121 and His263 317 ( Figure 4) . In both subunits the two zinc ions lie approximately 3.5 Å apart (distances 3.46 Å and 318 3.51 Å in chains A and B, respectively) and are connected by a "bridging" water molecule 319 (Wat1, likely to exist as an hydroxide ion (54)) that is positioned asymmetrically with respect to 320 the two metal ions and lies closer to Zn1 (1.81 -1.90 Å) than to Zn2 (2.04 -2.11 Å). Metal co-321 ordination is completed by a second water molecule (Wat2) that lies closer to Zn2 but also co-322 ordinates Zn1 (Wat2 -Zn1 distances 2.57 and 2.68 Å in chains A and B, respectively), and can 323 thus also be considered to bridge the two metal ions. In consequence both Rm3 metal ions are 324 five co-ordinated. 325
Five co-ordinate metal ion systems can be described using the structural parameter τ (τ = (β -326 α)/60) to discriminate between trigonal (τ = 1) and square (τ = 0) pyramidal geometries (55). For 327 the Rm3 Zn1 site the two angles α and β that represent distortion from square to trigonal 328 bipyramidal co-ordination can be defined as His116 -Zn1 -His196 (103.5º) and Wat2 -Zn1 -329
His118 (167.4º), respectively (56), yielding a value for τ of 1.07 and indicating that co-330 ordination is best described as trigonal bipyramidal. architecture. Hydrophobic residues (Phe156 and Ile162) in loop1 of L1 were proposed to participate in binding of substrate (59), but subsequent directed mutagenesis investigations of L1 359 (62) and FEZ-1 (63) did not identify these individual positions as essential to activity. However, 360 rapid kinetic experiments (64) demonstrate that this loop can adjust its position during turnover 361 of β-lactams by the L1 enzyme, indicating that the structure as a whole may have some 362 mechanistic role. In addition, both AIM-1 and SMB-1 feature a Gln at position 157, where 363 models of bound cephalosporin substrates suggest that it may interact with the carboxylate group 364 at C7/C8 formed on hydrolysis of the β-lactam amide (57, 61). In Rm3 Gln157 is present, as part 365 of a DPQ motif that is also found in SMB-1, AIM-1 and THIN-B, and the organization of loop1 366 closely resembles that found in AIM-1 and SMB-1 ( Figure 5 ). By way of contrast, loop1 in the 367 L1, FEZ-1 and BJP-1 structures adopts a more "open" conformation than is the case here. 368
Loop2 (residues 224 -230) is the third region of variability between B3 MBL structures. In 369 common with AIM-1 and SMB-1, loop2 of Rm3 is longer by two residues than its equivalent in 370 other B3 enzymes, with the apex of this loop extending away from the active site. In L1 and 371 FEZ-1, residues such as Asn225 (FEZ-1) and Tyr228 (both enzymes) on loop2 are proposed to 372 contribute to β-lactam hydrolysis through interaction with the C7/C8 carboxylate group of 373 hydrolyzed species (see above) (59, 60, 62) . Consistent with the presence of Gln157 on loop1 374 (see above) which could act as a functional replacement for these residues, the equivalent 375 positions of Rm3 loop2 are occupied by amino acids (Val and Pro) that are unable to replicate 376 these proposed interactions, and the conformation of loop2 is also incompatible with a 377 contribution to β-lactam binding and/or hydrolysis. Loop2 of BJP-1 also differs from the 378 equivalent regions of L1 and FEZ-1, but in this case it is positioned in a more "closed" 379 conformation nearer to the zinc center. Taken together, these comparisons indicate that, in both 380 the overall fold, and the specific architecture of variable regions (loops 1 and 2) adjacent to the active site, the Rm3 structure more closely resembles that of the mobile B3 enzymes AIM-1 and 382 SMB-1 than it does the chromosomal B3 MBLs L1, FEZ-1 and BJP-1. 383
In contrast to these clear differences in overall structure between different B3 MBLs, comparison 384 of the respective active sites indicates that the principal features of the Rm3 metal center are 385 common between all structurally characterized B3 MBLs. Specifically, all B3 MBLs of known 386 structure feature a binuclear zinc center with a five co-ordinate ion in the Zn2 site and geometry 387 intermediate between trigonal bi-and square pyramidal, and (for structures that do not contain 388 bound ligands) the zinc -zinc distance (3.46 Å and 3.51 Å in Rm3 chains A and B, respectively 389 (see above)) varies between 3.40 and 3.58 Å (for structures determined at resolutions between 390 1.40 Å and 1.80 Å, compared to a resolution of 1.75 Å for the structure of Rm3 presented here). 391
With respect to other B3 enzymes, the main difference in the Rm3 active site is the positioning 392 of the Wat2 water molecule (Figure 4b, c) , which is notably closer to both Zn1 (distances 2.57 Å 393 and 2.68 Å in Rm3 chains A and B, respectively) and Wat1 (2.33 Å and 1.96 Å) than is the case 394 in e.g L1 (Wat2 -Zn1 and Wat2 -Wat1 distances 2.80 Å and 3.04 Å for pdb 1SML). 395 396
Implications of Rm3 Structure for Activity 397
Despite much effort, the precise mode of binding of β-lactams to the active site of B3 MBLs 398 remains incompletely understood. In fact only one crystal structure has so far been determined 399 for a B3 MBL complexed with antibiotic, that of L1 bound to the hydrolysis product of the 400 oxacephem moxalactam (65); docking and quantum mechanics/molecular mechanics (QM/MM) 401 approaches have been used to investigate interactions of AIM-1 with hydrolyzed cefoxitin (61). 402
We therefore used superposition of the Rm3 and L1:moxalactam structures to consider possible interactions of hydrolyzed moxalactam with Rm3 (Figure 6a, b) in an effort to investigate 404 determinants of β-lactamase activity, and the basis for the high K M values that are observed for 405 β-lactam hydrolysis by Rm3. 406 Consistent with the ability of Rm3 to hydrolyze most classes of β-lactam, these comparisons 407 imply that the enzyme can replicate many of the interactions with substrates made by L1 or 408 AIM-1. In addition to interactions involving the two metal ions (Zn1 with the C7/C8 409 carbonyl/carboxylate of the β-lactam amide, and Zn2 with the C3/C4 carboxylate of the second 410 ring), the Rm3 active site contains conserved residues at positions previously implicated in β-411 lactam binding. In particular, Ser221, a residue that is highly conserved in B3 MBLs, and 412
Asn223 (Ser or Thr in most other B3 enzymes) are well positioned to contact the C3/C4 413 carboxylate of bound β-lactam. Notably, in the Rm3 crystal structure the anticipated positions 414 adopted by the β-lactam carboxylate oxygen atoms are occupied by Wat2 and by a second water 415 molecule (Wat3) positioned between the Ser221 and Asn223 side chains. As noted earlier, and as 416 has been proposed for AIM-1 (61) and SMB-1 (57), the Gln157 side chain is positioned to 417 contact the C7/C8 carboxylate generated by β-lactam hydrolysis. Furthermore, the conserved 418 Trp41 side chain is able to make hydrophobic interactions with the β-lactam core. Rm3 is thus 419 able to make productive interactions with the core components common across the different 420 classes of β-lactam. 421
Given this apparent availability of productive modes of substrate binding, we then considered 422 why Rm3 hydrolyzes β-lactams with relatively low efficiency. Inspection of molecular surfaces 423 in the vicinity of the active site (Figure 6c, d) indicates that, compared to other B3 enzymes in 424 which the active site sits in a relatively shallow groove, the Rm3 active site is positioned at the bottom of a much deeper channel that runs across one side of the structure. Notably, the extended 426 N-terminus forms one wall of this cleft in the region that would be expected to form the binding 427 site for the C6/C7 (R1) substituent of β-lactams, either requiring substrates to adopt specific 428 conformations on binding to avoid steric clashes, or necessitating significant conformational 429 changes of the enzyme to render the active site more accessible to β-lactams, particularly those 430 such as later generation cephalosporins (e.g. ceftazidime) with bulky C7 substituents. 431
Interestingly, for the B3 MBL BJP-1, where in the unliganded enzyme the active site is occluded 432 by the extended N-terminal α-helix, the crystal structure of a complex with a 4-433 nitrobenzenesulfonamide inhibitor showed that inhibitor binding involved displacement of this 434 entire helix from its position in the native structure in order to make the active site accessible 435 (53). We thus propose that the high K M values for Rm3-catalyzed hydrolysis of β-lactams arise 436 in large part from the steric constraints upon substrate binding that are imposed by the extended 437 N-terminus. It is possible that the additional proline-rich N-terminal sequence, comprising a 438 further 10 amino acids that could not be modeled in our final crystal structure, could impose 439 further restrictions upon substrate binding. 440 441
Concluding Remarks 442
The increasing availability of sequence information from genomic and metagenomics projects 443 has begun to establish the extent to which antibiotic resistance genes are distributed in the wider 444 environment. It is now clear that MBLs, and the B3 subclass in particular, are frequently present 445 on the chromosomes of environmental organisms that include, but are not limited to, opportunist 446 human pathogens such as S. maltophilia or E. meningosepticum. Accumulating evidence shows that the antibiotic era has been characterized by repeated instances of the mobilization of 448 resistance determinants from environmental species, such as Kluyvera or Shewanella spp., into 449 clinically significant pathogens, and their subsequent global dissemination on multiresistance 450 plasmids. It is also becoming apparent that exposure to detergents and biocides, as well as 451 antibiotics, may also be implicated in the mobilization of resistance genes, and co-selection of 452 multiresistance elements. In this work we describe the properties of the product of a novel 453 resistance gene, bla Rm3 , that was identified from an environment with high levels of biocide 454 exposure. 455 bla Rm3 encodes a B3 MBL that is active against most β-lactam classes in vitro and is able to 456 reduce the cephalosporin susceptibility of recombinant E. coli, thus replicating characteristics of 457 enzymes of clinical importance. Sequence-based phylogeny indicates that Rm3 is representative 458 of a distinct clade of B3 MBLs that differs from the L1 and FEZ-1/GOB groups (Figure 2) . It is 459 likely that, given their occurrence in environmental samples from sites that differ greatly in their 460 geographical location and level of human impact, these enzymes have a wide distribution in the 461 environment. With increasing use of broad-spectrum β-lactams, and the associated increase in 462 selection pressure, there is thus considerable potential for future mobilization of MBLs of this 463 type into the clinic. The structure of Rm3 demonstrates an overall resemblance to the mobilized 464 AIM-1 and SMB-1 enzymes, and provides a basis both for the β-lactamase activity of Rm3 and 465 the limited efficiency with which it hydrolyzes most substrates. However, the architecture of the 466 active site that is created by the extended N-terminus distinguishes Rm3 from other B3 MBLs 467 that have been studied so far, suggesting both that (as has been suggested for other B3 MBLs 468 (50)) β-lactams may not necessarily be the natural substrates for these enzymes, and that there is capacity for β-lactamase activity to be improved by mutation. Future experiments will 470 investigate these possibilities. 471 
